T14

Navistar Launches International® S13 Integrated Powertrain for Vocational Market

Retrieved on: 
Tuesday, March 14, 2023
Diamond, SCR, Traton, T14, International, OCC, Series, Particulates, DOC, Maintenance, Navistar, International Truck of the Year, Patent, Safety, Dual, Friction, Stasel Falls, EGR, Commercial Operating System, S13, AMT, Torque, Las Vegas Convention Center, Soot, Automotive industry, Printed circuit board, Hydraulic machinery, Heavy equipment

LISLE, Ill., March 14, 2023 /PRNewswire/ -- Navistar has launched the International® S13 Integrated Powertrain for the vocational market. The S13 Integrated Powertrain, developed in collaboration with the TRATON Group, demonstrates advancements in robustness, reliability and performance. This latest announcement showcases a continued commitment to customers by setting the foundation for the next generation of vehicles, technologies and comprehensive ownership solutions.

Key Points: 
  • LISLE, Ill., March 14, 2023 /PRNewswire/ -- Navistar has launched the International® S13 Integrated Powertrain for the vocational market.
  • "The S13 Integrated Powertrain is the most advanced powertrain we've ever produced and the lightest vocational powertrain available on the market," said Mark Stasell, vice president, Vocational Truck Business.
  • "The S13 Integrated will benefit vocational customers by achieving stellar performance, simplicity and serviceability, and superior operating economy."
  • Navistar first introduced the S13 Integrated Powertrain for the on-highway market in August 2022, available in the International® LT® and RH™ Series models.

Accelerate Digital Transformation in a Hybrid World with Latest Lenovo PC Solutions

Retrieved on: 
Sunday, February 26, 2023
Software, Audio, Video, Hardware, Consumer Electronics, Technology, Online Retail, Retail, Other Technology, T14, PC, ThinkPad T series, ThinkPad Yoga, ThinkPad, Intel, ThinkBook, Data as a service, Tiny, ThinkCentre, Light, T14 (satellite), Lenovo, PCC, Organization, Algorithm, Aviation, Series, TIO, Infrared, Dolby, SRGB, Student, Processor, ThinkPad X1 series, Carbon, Chromebook, Windows 11, OLED, SSD, T16, FHD, L14, L15, HDMI, Immersion, ThinkPad L series, PET, Z16, TB, Multimedia, IdeaPad, ChromeOS, Intelligence, Modularity, L series, Facial recognition, Voice over IP, AMD, Biofuel, DisplayPort, PCI Express, Flax, Satellite navigation device, Video game, Recycling, Television

Today at MWC™ 2023, Lenovo unveiled its latest PC and Chromebook solutions to help embrace dispersed hybrid working styles and provide advanced features that empower users across a broad selection of needs.

Key Points: 
  • Today at MWC™ 2023, Lenovo unveiled its latest PC and Chromebook solutions to help embrace dispersed hybrid working styles and provide advanced features that empower users across a broad selection of needs.
  • Encompassing a progressive and contemporary design philosophy, the latest PC solutions, including a comprehensive refresh across the ThinkPad portfolio, focus on improvements in system performance, increased use of more sustainable materials, and better user experience.
  • Lenovo also introduced a redesigned fourth generation ThinkPad X13 and X13 Yoga with narrower bezels, new colors, materials and features to facilitate hybrid work and mobility.
  • The highly versatile ThinkCentre Tiny-in-One Gen 5 Monitor offers improved audio-visual capabilities and redesigned features capable of supporting multiple work scenarios.

Novel Drug From Neuro-Bio Effective in a Mouse Model of Alzheimer’s Disease

Retrieved on: 
Wednesday, April 6, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Spinal cord, Brain, Neuroscience, Alzheimer's disease, Neurodegeneration, Non-executive director, Human, Regulation, Medication, Patent, Â, Acetylcholinesterase, Neuro, Research, Hippocampus, Cell damage, Pathology, Associate, University of Oxford, Neuropharmacology, Parkinson's disease, CEO, Amyloid, Center, Experimental Brain Research, Neuroprotection, T14, Nasal administration, Neurotoxicity, UCLA, Light, Medicines and Healthcare products Regulatory Agency, Disease, Neurology, Pharmaceutical industry, Fine chemical, Vaccine, Medical imaging, Medicine, NEURO-BIO, NBP14

Neuro-Bio Ltd , a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimers disease.

Key Points: 
  • Neuro-Bio Ltd , a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimers disease.
  • Publishing their work in Alzheimers & Dementia: Translational Research & Clinical Interventions (TRCI) , Neuro-Bio researchers, in collaboration with the drug discovery company Evotec SE, UCLA, and Kings College London studied the ability of their patented drug, NBP14, to combat neurodegeneration in an established mouse model of Alzheimers disease.
  • The results underscore the effectiveness of Neuro-Bios drug candidate and represent a remarkable step forward towards the treatment of Alzheimers disease in humans.
  • Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer's Disease.